The Medical Device Recall Improvement Act of 2025 would amend the Federal Food, Drug, and Cosmetic Act to require an electronic format for device recall notifications and patient-facing information. It creates a structured, machine-readable process for recalls, including a data template, an electronic submission system, and a public database of recall notices.
It also adds patient notification requirements and establishes penalties for noncompliance, along with funding to implement the program.
Key elements include a two-year deadline for establishing the electronic form and data elements, initial and ongoing manufacturer notifications through the electronic format, and a patient-notification provision tied to recall actions. The act is designed to standardize communications to manufacturers, health professionals, device user facilities, and patients, with a dedicated budget to support its rollout and operation.
At a Glance
What It Does
The Secretary must publish an electronic form and manner for device recall notifications within two years, mandating data elements such as manufacturer, device identifier, risk, and patient-facing guidance. It also requires an electronic, publicly accessible database of recall notifications and sets rules for initial and subsequent electronic communications to facilities, professionals, and patients.
Who It Affects
Manufacturers and importers of medical devices, device user facilities (hospitals, clinics), health professionals, patients, and the FDA’s recall program staff.
Why It Matters
Standardized, rapid, and transparent recall communications can reduce patient exposure to risky devices and improve actionability for clinicians and facilities. A public database enhances oversight and accountability by making recall information readily accessible.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill adds new sections to the Federal Food, Drug, and Cosmetic Act to overhaul how medical device recalls are communicated. Section 518B requires the Secretary to publish an electronic format for recall notifications within two years, with a mandatory data set that includes the manufacturer name and contact, device identifiers, the recall rationale, and the recommended actions for facilities, health professionals, and patients.
It also authorizes optional data fields the Secretary may determine are appropriate and directs the Department to maintain a publicly accessible database of all recall notifications.
Notifications must flow through the electronic system. Beginning 180 days after the form is established, manufacturers or importers must submit recalls under 519(g) electronically.
The Secretary must perform an initial review within two business days and, within three business days after the review, communicate to manufacturers what information should be shared with facilities and health professionals. After the initial notice, manufacturers must provide any additional notifications through the same electronic format as needed.518C adds a patient-notification requirement.
Recall strategies under 519(g) must include notice to patients treated with the device by facilities and health professionals, including risk information and recommended actions to mitigate risk. The rule applies to specific high-risk recalls, including devices implanted in the body, life-sustaining or life-supporting devices, or devices used in pediatric populations outside of facilities.
The act also clarifies that facilities and health professionals are not obligated to relay information to manufacturers, preserving patient privacy and role boundaries. Finally, Section 3 adds penalties to the FD&C Act for failing to submit notifications or provide required patient notices, and it authorizes appropriations to support implementation from 2026 through 2030.
The Five Things You Need to Know
The Secretary must publish an electronic recall notification form and data elements within two years of enactment, with mandatory fields such as manufacturer name, device identifier, and risk information.
The system requires recalls to be submitted electronically to the Secretary under section 519(g) starting 180 days after the form is established, with defined initial and follow-up notification workflows.
A publicly accessible electronic database of recall notifications will be maintained by the Secretary, enabling download and public inspection.
Patient notification is mandated for recall strategies, requiring information about risks and actions for patients treated with the device, especially for high-risk classes and off-facility uses.
Noncompliance with 518B or 518C recall requirements triggers penalties under §301 of the FD&C Act, and funding is authorized for 2026–2030 to support implementation.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Electronic notification format for recalls
This section requires the Secretary to publish an electronic form and method for device recall notifications within two years of enactment. The format must be electronic and include mandatory data elements such as the manufacturer name and contact, the device identifier, the recall reason, and information for device user facilities, health professionals, and patients about risks and actions. It also allows for optional data elements at the Secretary’s discretion, enabling richer context if needed.
Notifications and data flow
Manufacturers or importers must submit recalls to the Secretary via the electronic format established under 518B. The Secretary conducts an initial review within two business days and then informs the manufacturer within three business days about what information should be shared with facilities and health professionals to support a safe and timely response.
Electronic database
The Secretary must maintain a publicly accessible electronic database populated with device recall notifications. This database is downloadable and serves as the central repository for standardized recall data, supporting oversight, transparency, and faster dissemination of critical risk information.
Patient notification requirements
Recall strategies must include notice to patients treated with the device. The secretary requires that these notices include risk information and explicit instructions to healthcare facilities and professionals on how to convey risk and actions to patients, particularly for high-risk uses outside of standard facility settings.
Prohibited acts and penalties
The bill adds penalties to the FD&C Act for failing to submit the mandated electronic notifications under 518B and for failing to provide patient notices under 518C. These additions create enforceable consequences for noncompliance and align penalties with the enhanced notification regime.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Device manufacturers and importers gain a clear, standardized framework for recalls, reducing ambiguity in reporting and speeding communications to regulators and healthcare providers.
- Device user facilities (hospitals, clinics, and outpatient centers) receive timely, uniform recall data and patient-facing guidance that supports safe patient care and rapid decisionmaking.
- Health professionals gain consistent risk information and recommended actions to relay to patients, improving clinical decision-making during recalls.
- Patients and patient advocacy groups benefit from clearer risk communication and actionable guidance to protect personal safety.
- FDA recall program staff benefit from a standardized data set and a public database that streamlines oversight and analysis.
Who Bears the Cost
- Manufacturers and importers must implement and maintain the electronic notification system, collect mandatory data elements, and ensure timely submissions, incurring IT and process costs.
- FDA program administrators face ongoing costs to operate and secure the electronic database, review data for quality and consistency, and manage user support.
- Health care providers and device user facilities may incur time and administrative overhead to incorporate new notices into patient care workflows and to communicate with patients.
Key Issues
The Core Tension
The central dilemma is balancing rigorous, standardized, and rapid recall communications with the practical realities and costs of implementing a nationwide electronic notification system, while ensuring patient privacy and meaningful, actionable information reaches patients without overwhelming providers.
The bill creates a coordinated, technology-enabled approach to device recalls, but it also introduces implementation challenges. Establishing the electronic form, data template, and public database requires substantial upfront work for the FDA and industry alike, with ongoing maintenance costs that Congress has begun to fund through annual appropriations.
The 180-day run-in period before manufacturers must use the electronic format gives industry time to adapt, but the actual deadline of two years for the form’s creation and the architecture of the data elements will require careful project management to avoid delays that could blunt the public safety benefits. The patient-notification requirement increases the likelihood that patients will receive timely information, yet it heightens concerns about privacy, information dissemination across diverse clinical settings, and the potential for information overload for patients unfamiliar with medical terminology.
Practitioners will need clear guidance on how to interpret and act on the posted data, especially in high-stakes recalls involving life-sustaining devices or pediatric populations.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.